A trial of lacosamide for benign convulsions with gastroenteritis.

Brain Dev

Department of Pediatrics, Aichi Medical University, Nagakute, Aichi, Japan. Electronic address:

Published: August 2020

AI Article Synopsis

  • Benign convulsions with gastroenteritis involve a series of seizures that can occur during illness.
  • A study administered lacosamide, a new sodium channel blocker, to five patients aged 17 to 33 months who had 1-4 generalized convulsions lasting from 30 to 120 seconds.
  • After receiving a single dose of lacosamide (2 mg/kg), the seizures stopped without any reported side effects.

Article Abstract

Benign convulsions with gastroenteritis are characterized by a cluster of seizures. Sodium channel blockers are efficacious. We prescribed lacosamide, a new channel blocker, for five patients. Patient age ranged from 17 to 33 months; all five experienced 1-4 generalized convulsions persisting for 30-120 s. One patient exhibited a transient splenial lesion on head magnetic resonance imaging. All received one dose (2 mg/kg) of lacosamide. The convulsions ceased, and no adverse drug effect was noted. A single dose of lacosamide was effective and well-tolerated in five patients with benign convulsions with gastroenteritis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.braindev.2020.03.006DOI Listing

Publication Analysis

Top Keywords

benign convulsions
12
convulsions gastroenteritis
12
convulsions
5
trial lacosamide
4
lacosamide benign
4
gastroenteritis benign
4
gastroenteritis characterized
4
characterized cluster
4
cluster seizures
4
seizures sodium
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!